A 26-year-old man developed atypical hemolytic uremic syndrome (aHUS) triggered by a lung infection and caused by a previously…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Relapses of Crohn’s disease, an inflammatory bowel condition, lessened the efficacy of Soliris (eculizumab) in an adolescent girl with…
Severe colon infection caused by the bacteria Clostridioides difficile triggered a rare case of atypical hemolytic uremic syndrome (aHUS)…
Ultomiris (ravulizumab) can safely and effectively treat women with atypical hemolytic uremic syndrome…
A common mutation in the CD46 gene associated with atypical hemolytic uremic syndrome (aHUS) onset does not…
The rejection of a kidney transplant was found to be the cause of intestinal bleeding and pain in…
Difficulties in diagnosing atypical hemolytic uremic (aHUS) syndrome in the absence of family…
The activity of a molecule called ADAMTS13 can predict the outcome of patients with with atypical hemolytic…